387 related articles for article (PubMed ID: 36733386)
1. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma.
Sae-Fung A; Mutirangura A; Jitkaew S
Front Immunol; 2022; 13():1051273. PubMed ID: 36733386
[TBL] [Abstract][Full Text] [Related]
2. Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma.
Wang Z; Zhang Y; Chen Y; Liu S; Li C; Li X
Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):181-191. PubMed ID: 35026122
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer.
Liu Y; Du S; Yuan M; He X; Zhu C; Han K; Zhu Y; Yang Q; Tong R
Front Pharmacol; 2022; 13():949126. PubMed ID: 36386203
[TBL] [Abstract][Full Text] [Related]
5. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
6. Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma.
Yao X; Chen B; Wang M; Zhang S; He B; Shi Z; Deng T; Bao W; Wang Y; Chen G; Bo Z
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1376-1385. PubMed ID: 36111744
[TBL] [Abstract][Full Text] [Related]
7. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma.
Yang L; Fan X; Zhou C; Wang Z; Cui Z; Wu X; Xu Z; Yang J; Zhang X
Transl Lung Cancer Res; 2023 Aug; 12(8):1766-1781. PubMed ID: 37691861
[TBL] [Abstract][Full Text] [Related]
9. Disulfidptosis and ferroptosis related genes predict prognosis and personalize treatment for hepatocellular carcinoma.
Liu JF; Huang L; Zhou XP; Li CR; Liu MF; Liang YH; Yu QH; Wu JR
Transl Cancer Res; 2024 Feb; 13(2):496-514. PubMed ID: 38482398
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
11. A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer.
Zhang Y; Liang Y; Wang Y; Ye F; Kong X; Yang Q
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36222299
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel model based on ferroptosis-related genes for predicting the prognosis of diffuse large B-cell lymphomas.
Wang J; Peng H; Zhang G; Yan W
Hematology; 2023 Dec; 28(1):2198862. PubMed ID: 37199349
[TBL] [Abstract][Full Text] [Related]
13. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma.
Shi J; Wu P; Sheng L; Sun W; Zhang H
Cancer Cell Int; 2021 Dec; 21(1):669. PubMed ID: 34906147
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
[TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract][Full Text] [Related]
17. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
Wang X; Meng Y; Liu C; Yang H; Zhou S
J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J
Front Oncol; 2021; 11():730716. PubMed ID: 34557413
[TBL] [Abstract][Full Text] [Related]
19. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
20. GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma.
Yin Z; Liu Q; Gao Y; Wang R; Qi Y; Wang D; Chen L; Yin X; He M; Li W
Mol Carcinog; 2024 May; 63(5):912-925. PubMed ID: 38390729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
